Finance

Lists
VREX:NASDAQ
Varex Imaging Corp
18,49 US$
0,00%
(0,00) 1D
2 ოქტ, 11:40:32 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VREX...
Open
18,50 US$
High
18,50 US$
Low
18,48 US$
Mkt. cap
785,15 მლნ.
Avg. vol.
676,98 ათ.
Volume
223,15 ათ.
P/E ratio
35,38
52-wk high
18,63 US$
52-wk low
9,09 US$
EPS
0,52 US$
Beta
0,97
Shares outstanding
42,46 მლნ.
No. of employees
2 ათ.
Open
18,50 US$
High
18,50 US$
Low
18,48 US$
Mkt. cap
785,15 მლნ.
Avg. vol.
676,98 ათ.
Volume
223,15 ათ.
P/E ratio
35,38
52-wk high
18,63 US$
52-wk low
9,09 US$
EPS
0,52 US$
Beta
0,97
Shares outstanding
42,46 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
About Varex Imaging Corp
CEO-
Employees2,5 ათ.
Founded2016
Headquartersსოლტ-ლეიკ-სიტი, იუტა, ამერიკის შეერთებული შტატები
SectorMedical device
Websitevareximaging.com
Analyst ratings
Based on 4 analysts giving stock ratings to VREX in the past 3 months
Hold
Buy
0
Hold
4
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for VREX in the last 3 months.
Highest
Current 18,49 US$
19,00 US$ (+2,76%)
Average
18,93 US$ (+2,38%)
Lowest
18,90 US$ (+2,22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lawrence Solow
CJS Securities
Hold
Downgraded
18,90 US$
+2,2%
08/17/2026
Suraj Kalia
Oppenheimer
Hold
Downgraded
18,90 US$
+2,2%
08/11/2026
Anderson Schock
B. Riley Securities
Hold
Downgraded
18,90 US$
+2,2%
08/10/2026
James Sidoti
Sidoti
Hold
Downgraded
19,00 US$
+2,8%
08/10/2026
Last report
10 აგვ. 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
0,31 US$ / 0,20 US$
+56,57%beat
Revenue / Est. (USD)
210,50 მლნ. / 215,50 მლნ.
-2,32%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ოქტ. 2025
იან. 2026
აპრ. 2026
ივლ. 2026
Revenue
228,90 მლნ.
209,60 მლნ.
216,00 მლნ.
210,50 მლნ.
Cost of goods sold
151,10 მლნ.
139,80 მლნ.
143,40 მლნ.
133,80 მლნ.
Cost of revenue
151,10 მლნ.
139,80 მლნ.
143,40 მლნ.
133,80 მლნ.
Research and development expenses
24,20 მლნ.
21,70 მლნ.
22,20 მლნ.
23,30 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34,00 მლნ.
32,70 მლნ.
36,00 მლნ.
30,60 მლნ.
Operating expense
58,20 მლნ.
54,40 მლნ.
58,20 მლნ.
53,90 მლნ.
Total operating expenses
209,30 მლნ.
194,20 მლნ.
201,60 მლნ.
187,70 მლნ.
Operating income
19,60 მლნ.
15,40 მლნ.
14,40 მლნ.
22,80 მლნ.
Other non operating income
6,70 მლნ.
-1,10 მლნ.
-2,70 მლნ.
-
EBT including unusual items
14,10 მლნ.
3,80 მლნ.
-6,40 მლნ.
16,20 მლნ.
EBT excluding unusual items
14,10 მლნ.
3,80 მლნ.
-6,40 მლნ.
15,60 მლნ.
Income tax expense
1,90 მლნ.
1,40 მლნ.
1,60 მლნ.
300,00 ათ.
Effective tax rate
13,48%
36,84%
-25,00%
1,85%
Other operating expenses
-
-
-
-
Net income
12,20 მლნ.
2,30 მლნ.
-8,10 მლნ.
15,70 მლნ.
Net profit margin
5,33%
1,10%
-3,75%
7,46%
Earnings per share
0,37
0,19
0,21
0,31
Interest and investment income
1,00 მლნ.
600,00 ათ.
400,00 ათ.
900,00 ათ.
Interest expense
-7,90 მლნ.
-7,90 მლნ.
-17,20 მლნ.
-5,80 მლნ.
Net interest expenses
-6,90 მლნ.
-7,30 მლნ.
-16,80 მლნ.
-4,90 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
26,30 მლნ.
22,20 მლნ.
21,20 მლნ.
29,80 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები